1-3 of 3
José Rifon
Close
Sort by
Journal Articles

SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

Ion Cristóbal, Francisco J. Blanco, Laura Garcia-Orti, Nerea Marcotegui, Carmen Vicente, José Rifon, Francisco J. Novo, Eva Bandres, María J. Calasanz, Carmelo Bernabeu, María D. Odero
Journal: Blood
Blood (2010) 115 (3): 615–625.
https://doi.org/10.1182/blood-2009-06-227363
Published: 2010
Includes: Supplemental data
Journal Articles

Secondary Malignancies after Autologous Stem Cell Transplantation for Hodgkin’s Lymphoma: Incidence and Analysis of Risk Factors.

Mireia Constans, Anna Sureda, Reyes Arranz, Maria Dolores Caballero, Juan Jose Lahuerta, Juan Carlos Hernandez-Boluda, Maria Jesus Vidal, Jose Garcia-Laraña, Jose Rifon, Josep Maria Ribera, Pascual Fernandez-Abellan, Jose Maria Moraleda, Maria Teresa Bernal, Maria Victoria Mateos, Maria Martin-Mateos, Rafael Cordoba, Javier Garcia-Conde, Jorge Sierra, Eulogio Conde, for the Spanish Cooperative Group (GEL/TAMO).
Journal: Blood
Blood (2004) 104 (11): 60.
https://doi.org/10.1182/blood.V104.11.60.60
Published: 2004
Journal Articles

Prognostic Factors and Long-Term Outcome for Patients with Hodgkin’s Lymphoma Who Relapse after an Autologous Stem Cell Transplantation.

Mireia Constans, Anna Sureda, Reyes Arranz, Maria Dolores Caballero, Juan Jose Lahuerta, Juan Carlos Hernandez-Boluda, Maria Jesus Vidal, Jose Garcia-Laraña, Jose Rifon, Josep Maria Ribera, Pascual Fernandez-Abellan, Jose Maria Moraleda, Maria Teresa Bernal, Maria Victoria Mateos, Maria Martin-Mateos, Rafael Cordoba, Javier Garcia-Conde, Jorge Sierra, Eulogio Conde, for the Spanish Cooperative Group GEL/TAMO
Journal: Blood
Blood (2004) 104 (11): 1649.
https://doi.org/10.1182/blood.V104.11.1649.1649
Published: 2004